Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 50Burkitt Lymphoma 28Leukemia, Biphenotypic, Acute 15Leukemia, Myeloid, Acute 13Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 10Leukemia 10Myelodysplastic Syndromes 9Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 7Osteosarcoma 6Lymphoma 6Leukemia, Myeloid, Accelerated Phase 6Blast Crisis 6Lymphoma, Non-Hodgkin 5Lymphoma, Mantle-Cell 5Lymphoma, Large B-Cell, Diffuse 5Graft vs Host Disease 5Medulloblastoma 4Down Syndrome 4Urinary Bladder Neoplasms 3Recurrence 3Primary Myelofibrosis 3Neoplasm Metastasis 3Myeloproliferative Disorders 3Leukemia, Myelomonocytic, Juvenile 3Hematologic Neoplasms 3Head and Neck Neoplasms 3Blastic Plasmacytoid Dendritic Cell Neoplasm 3Thrombocythemia, Essential 2Rhabdoid Tumor 2Polycythemia Vera 2

Interventions

Cyclophosphamide 48Rituximab 32fludarabine 29Doxorubicin 14Specimen Handling 13Magnetic Resonance Spectroscopy 13Vincristine 12Prednisone 12pirtobrutinib 11fludarabine phosphate 10Etoposide 10Bendamustine Hydrochloride 10Immunotherapy, Adoptive 9obinutuzumab 8Lenalidomide 8Biopsy 8venetoclax 7polatuzumab vedotin 7pembrolizumab 7glofitamab 7zanubrutinib 6Dexamethasone 6tafasitamab 5ibrutinib 5etoposide phosphate 5acalabrutinib 5Leukapheresis 5tazemetostat 4loncastuximab tesirine 4Nivolumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, B-Cell × Methotrexate × 1 year × Clear all
NCT01516580 2026-02-09

Intergroup Randomized Trial for Children or Adolescents With B-Cell Non Hodgkin Lymphoma or B-Acute Leukemia: Rituximab Evaluation in High Risk Patients

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Completed
482 enrolled 1 FDA
Lymphoid

Burkitt Lymphoma, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡